Haemonetics (HAE) Competitors $59.29 -0.75 (-1.25%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HAE vs. ALGN, MMSI, ICUI, XRAY, QDEL, NEOG, STAA, CERS, OSUR, and ANIKShould you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), and Anika Therapeutics (ANIK). These companies are all part of the "health care supplies" industry. Haemonetics vs. Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA QuidelOrtho Neogen STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Haemonetics (NYSE:HAE) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, community ranking, analyst recommendations, dividends, earnings and institutional ownership. Does the MarketBeat Community prefer HAE or ALGN? Align Technology received 392 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 69.87% of users gave Align Technology an outperform vote while only 61.60% of users gave Haemonetics an outperform vote. CompanyUnderperformOutperformHaemoneticsOutperform Votes40161.60% Underperform Votes25038.40% Align TechnologyOutperform Votes79369.87% Underperform Votes34230.13% Is HAE or ALGN more profitable? Align Technology has a net margin of 10.54% compared to Haemonetics' net margin of 9.47%. Haemonetics' return on equity of 23.66% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Haemonetics9.47% 23.66% 8.82% Align Technology 10.54%13.84%8.51% Does the media favor HAE or ALGN? In the previous week, Align Technology had 20 more articles in the media than Haemonetics. MarketBeat recorded 27 mentions for Align Technology and 7 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.34 beat Align Technology's score of 1.20 indicating that Haemonetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 16 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, HAE or ALGN? Haemonetics has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500. Do institutionals & insiders have more ownership in HAE or ALGN? 99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.8% of Haemonetics shares are owned by insiders. Comparatively, 0.6% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, HAE or ALGN? Align Technology has higher revenue and earnings than Haemonetics. Haemonetics is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHaemonetics$1.37B2.17$117.56M$2.5423.34Align Technology$4.00B3.04$421.36M$5.6129.56 Do analysts prefer HAE or ALGN? Haemonetics currently has a consensus target price of $101.22, indicating a potential upside of 70.72%. Align Technology has a consensus target price of $262.64, indicating a potential upside of 58.37%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts clearly believe Haemonetics is more favorable than Align Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Haemonetics 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78Align Technology 1 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.77 SummaryAlign Technology beats Haemonetics on 11 of the 18 factors compared between the two stocks. Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HAE vs. The Competition Export to ExcelMetricHaemoneticsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$2.98B$4.10B$5.36B$18.59BDividend YieldN/A39.53%5.11%4.25%P/E Ratio23.3427.6221.7131.16Price / Sales2.1746.33376.1026.51Price / Cash10.4851.0838.1517.54Price / Book3.285.826.444.30Net Income$117.56M$67.09M$3.20B$1.02B7 Day Performance0.56%2.02%6.23%4.42%1 Month Performance-9.84%-6.39%-6.64%-6.62%1 Year Performance-30.43%11.12%8.19%0.15% Haemonetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HAEHaemonetics4.5805 of 5 stars$59.29-1.2%$101.22+70.7%-29.6%$2.98B$1.37B23.342,820Short Interest ↓Positive NewsALGNAlign Technology4.6693 of 5 stars$153.35-0.1%$262.64+71.3%-47.9%$11.23B$4.00B27.3421,610Analyst RevisionNews CoveragePositive NewsMMSIMerit Medical Systems4.4794 of 5 stars$92.51+0.0%$111.70+20.7%+26.7%$5.46B$1.36B45.356,950Analyst ForecastShort Interest ↓Positive NewsHigh Trading VolumeICUIICU Medical3.7609 of 5 stars$142.25+2.1%$168.67+18.6%+45.3%$3.49B$2.38B-31.1314,500XRAYDENTSPLY SIRONA4.8244 of 5 stars$13.24-2.5%$23.33+76.2%-59.2%$2.63B$3.79B-6.4015,000Analyst RevisionNews CoveragePositive NewsGap DownQDELQuidelOrtho4.282 of 5 stars$28.36+0.8%$51.20+80.5%-36.2%$1.91B$2.78B-0.947,000Gap UpHigh Trading VolumeNEOGNeogen3.1938 of 5 stars$7.85+0.6%$14.00+78.3%-54.9%$1.70B$913.83M-3.582,110Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeSTAASTAAR Surgical4.2612 of 5 stars$16.14+1.4%$25.29+56.7%-66.3%$796.11M$313.90M-39.37960Positive NewsGap DownCERSCerus2.4623 of 5 stars$1.24flat$4.00+222.6%-21.1%$230.38M$180.27M-11.27290Positive NewsGap UpOSUROraSure Technologies4.6763 of 5 stars$3.01-3.2%$5.50+82.7%-46.9%$225.15M$185.83M20.07840News CoveragePositive NewsANIKAnika Therapeutics3.818 of 5 stars$13.92-0.6%$22.00+58.0%-45.4%$197.33M$119.91M-2.09300Gap Up Remove Ads Related Companies and Tools Related Companies Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives QuidelOrtho Alternatives Neogen Alternatives STAAR Surgical Alternatives Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HAE) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HAE Stock Free HAE Stock Alerts